Document Detail


Treatable inborn errors of metabolism presenting as cerebral palsy mimics: systematic literature review.
MedLine Citation:
PMID:  25433678     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BackgroundInborn errors of metabolism (IEMs) have been anecdotally reported in the literature as presenting with features of cerebral palsy (CP) or misdiagnosed as `atypical CP¿. A significant proportion is amenable to treatment either directly targeting the underlying pathophysiology (often with improvement of symptoms) or with the potential to halt disease progression and prevent/minimize further damage.MethodsWe performed a systematic literature review to identify all reports of IEMs presenting with CP-like symptoms before 5 years of age, and selected those for which evidence for effective treatment exists.ResultsWe identified 54 treatable IEMs reported to mimic CP, belonging to 13 different biochemical categories. A further 13 treatable IEMs were included, which can present with CP-like symptoms according to expert opinion, but for which no reports in the literature were identified. For 26 of these IEMs, a treatment is available that targets the primary underlying pathophysiology (e.g. neurotransmitter supplements), and for the remainder (n¿=¿41) treatment exerts stabilizing/preventative effects (e.g. emergency regimen). The total number of treatments is 50, and evidence varies for the various treatments from Level 1b, c (n¿=¿2); Level 2a, b, c (n¿=¿16); Level 4 (n¿=¿35); to Level 4¿5 (n¿=¿6); Level 5 (n¿=¿8). Thirty-eight (57%) of the treatable IEMs mimicking CP can be identified by ready available metabolic screening tests in blood or urine, while the remaining IEMs require more specific and sometimes invasive tests.ConclusionsLimited by the rare nature of IEMs and incomplete information in the literature, we conclude that (1) A surprisingly large number of IEMs can present with CP symptoms, as `CP mimics¿, (2) Although individually rare, a large proportion of these diseases are treatable such that neurological damage can either be reversed or prevented, (3) clinician awareness of treatable CP mimics is important for appropriate screening, diagnosis, and early intervention, and (4) systematic studies are required to elucidate the collective frequency of treatable IEMs in CP.
Authors:
Emma L Leach; Michael Shevell; Kristin Bowden; Sylvia Stockler-Ipsiroglu; Clara van Karnebeek
Related Documents :
1865578 - Hypophosphatasia in an adult: a case report.
9258598 - Mr demonstration of cerebral hemimegalencephaly associated with cerebellar involvement ...
630188 - Thecal deformity after lumbar myelography with iophendylate (myodil) and meglumine ioth...
15993018 - Importance of radiological diagnosis applied to necroscopy.
12587628 - Stenotrophomonas maltophilia endocarditis.
23405008 - Salmonella typhi presenting as acute glomerulonephritis in twin siblings.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-11-30
Journal Detail:
Title:  Orphanet journal of rare diseases     Volume:  9     ISSN:  1750-1172     ISO Abbreviation:  Orphanet J Rare Dis     Publication Date:  2014 Nov 
Date Detail:
Created Date:  2014-11-30     Completed Date:  -     Revised Date:  2014-12-1    
Medline Journal Info:
Nlm Unique ID:  101266602     Medline TA:  Orphanet J Rare Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  197     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Microbes on the edge of Occam¿s razor.
Next Document:  Ethical and scientific considerations for patient enrollment into concurrent clinical trials.